PATENT CLAIM ANALYSIS

Application Number: 16170487
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "167000"]

Abstract:
This present disclosure is directed to novel prodrugs of activated vitamin D 3  compounds. The prodrugs can be designed to have one or more beneficial properties, such as selective inhibition of the enzyme CYP24, low calcemic activity, and anti-proliferative activity. Specifically, these prodrugs are 1-deoxy prohormones of active Vitamin D analogs, e.g. analogs of calcitriol. This disclosure is also directed to pharmaceutical and diagnostic compositions containing the prodrugs of the invention, and to their medical use, particularly as prodrugs in the treatment and/or prevention of diseases.

Claim (Index 11):
The method of  claim 9 , wherein the method comprises treating a disease which benefits from an inhibition of the catabolism of 1\u03b1,25-dihydroxyvitamin D 3 .

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13521980', '10270158', '10612302', '11912395', '10738248']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826246806089218
- 35 USC 102 Novelty (BERT): 0.6928098421025983
- Combined Prediction Score: 0.7736431967582894
- Mean Citation Score: 476.151318
- Max Citation Score: 735.80597
- Similarity Product: 678.2684119346845

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test